|
|
|
|
| LEADER |
04531nam a22011657a 4500 |
| 003 |
AR-BaUEN |
| 005 |
20230612131437.0 |
| 008 |
230531s2022 xxuaod|f |||| 001 0 eng d |
| 020 |
|
|
|a 9781621824213
|
| 040 |
|
|
|a AR-BaUEN
|b spa
|c AR-BaUEN
|
| 044 |
|
|
|a xxu
|
| 080 |
|
|
|a 547.454
|
| 245 |
0 |
|
|a Essentials of glycobiology /
|c edited by Ajit Varki ... [et al.]
|
| 250 |
|
|
|a 4th ed.
|
| 260 |
|
|
|a New York, NY :
|b Cold Spring Harbor Laboratory Press,
|c c2022
|
| 300 |
|
|
|a xxxiii, 859 p. :
|b il color, fotos color, gráfs. color
|
| 500 |
|
|
|a Incluye guía de estudio al final de la obra.
|
| 504 |
|
|
|a Incluye glosario e índice analítico de materias.
|
| 504 |
|
|
|a Lecturas sugeridas al final de cada capítulo.
|
| 505 |
0 |
0 |
|t General principles
|
| 505 |
0 |
0 |
|g 1
|t Historical background and overview
|
| 505 |
0 |
0 |
|g 2
|t Monosaccharide diversity
|
| 505 |
0 |
0 |
|g 3
|t Oligosaccharides and polysaccharides
|
| 505 |
0 |
0 |
|g 4
|t Cellular organization of glycosylation
|
| 505 |
0 |
0 |
|g 5
|t Glycosylation precursors
|
| 505 |
0 |
0 |
|g 6
|t Glycosyltransferases and glycan-processing enzymes
|
| 505 |
0 |
0 |
|g 7
|t Biological functions of glycans
|
| 505 |
0 |
0 |
|g 8
|t A genomic view of glycobiology
|
| 505 |
0 |
0 |
|t Structure and Biosynthesis
|
| 505 |
0 |
0 |
|g 9
|t N-glycans
|
| 505 |
0 |
0 |
|g 10
|t O-GalNAc glycans
|
| 505 |
0 |
0 |
|g 11
|t Glycosphingolipids
|
| 505 |
0 |
0 |
|g 12
|t Glycosylphosphatidylinositol anchors
|
| 505 |
0 |
0 |
|g 13
|t Other classes of eukaryotic glycans
|
| 505 |
0 |
0 |
|g 14
|t Structures common to different glycans
|
| 505 |
0 |
0 |
|g 15
|t Sialic acids and other nonulosonic acids
|
| 505 |
0 |
0 |
|g 16
|t Hyaluronan
|
| 505 |
0 |
0 |
|g 17
|t Proteoglycans and sulfated glycosaminoglycans
|
| 505 |
0 |
0 |
|g 18
|t Nucleocytoplasmic glycosylation
|
| 505 |
0 |
0 |
|g 19
|t The O-GlcNAc modification
|
| 505 |
0 |
0 |
|t Glycans in Evolution and Development
|
| 505 |
0 |
0 |
|g 20
|t Evolution of glycan diversity
|
| 505 |
0 |
0 |
|g 21
|t Eubacteria
|
| 505 |
0 |
0 |
|g 22
|t Archaea
|
| 505 |
0 |
0 |
|g 23
|t Fungi
|
| 505 |
0 |
0 |
|g 24
|t Viridiplantae and algae
|
| 505 |
0 |
0 |
|g 25
|t Nematoda
|
| 505 |
0 |
0 |
|g 26
|t Arthropoda
|
| 505 |
0 |
0 |
|g 27
|t Deuterostomes
|
| 505 |
0 |
0 |
|t Glycan-Binding Proteins
|
| 505 |
0 |
0 |
|g 28
|t Discovery and classification of glycan-binding proteins
|
| 505 |
0 |
0 |
|g 29
|t Principles of glycan recognition
|
| 505 |
0 |
0 |
|g 30
|t Structural biology of glycan recognition
|
| 505 |
0 |
0 |
|g 31
|t R-type lectins
|
| 505 |
0 |
0 |
|g 32
|t L-type lectins
|
| 505 |
0 |
0 |
|g 33
|t P-type lectins
|
| 505 |
0 |
0 |
|g 34
|t C-type lectins
|
| 505 |
0 |
0 |
|g 35
|t I-type lectins
|
| 505 |
0 |
0 |
|g 36
|t Galectins
|
| 505 |
0 |
0 |
|g 37
|t Microbial lectins: hemagglutinins, adhesins, and toxins
|
| 505 |
0 |
0 |
|g 38
|t Proteins that bind sulfated glycosaminoglycans
|
| 505 |
0 |
0 |
|t Glycans in Physiology and Disease
|
| 505 |
0 |
0 |
|g 39
|t Glycans in glycoprotein quality control
|
| 505 |
0 |
0 |
|g 40
|t Free glycans as bioactive molecules
|
| 505 |
0 |
0 |
|g 41
|t Glycans in systemic physiology
|
| 505 |
0 |
0 |
|g 42
|t Bacterial and viral infections
|
| 505 |
0 |
0 |
|g 43
|t Parasitic infections
|
| 505 |
0 |
0 |
|g 44
|t Genetic disorders of glycan degradation
|
| 505 |
0 |
0 |
|g 45
|t Congenital disorders of glycosylation
|
| 505 |
0 |
0 |
|g 46
|t Glycans in acquired human diseases
|
| 505 |
0 |
0 |
|g 47
|t Glycosylation changes in cancer
|
| 505 |
0 |
0 |
|t Methods and a Applications
|
| 505 |
0 |
0 |
|g 48
|t Glycan-recognizing probes as tools
|
| 505 |
0 |
0 |
|g 49
|t Glycosylation mutants of cultured mammalian cells
|
| 505 |
0 |
0 |
|g 50
|t Structural analysis of glycans
|
| 505 |
0 |
0 |
|g 51
|t Glycomics and glycoproteomics
|
| 505 |
0 |
0 |
|g 52
|t Glycoinformatics
|
| 505 |
0 |
0 |
|g 53
|t Chemical synthesis of glycans and glycoconjugates
|
| 505 |
0 |
0 |
|g 54
|t Chemoenzymatic synthesis of glycans and glycoconjugates
|
| 505 |
0 |
0 |
|g 55
|t Chemical tools for inhibiting glycosylation
|
| 505 |
0 |
0 |
|g 56
|t Glycosylation engineering
|
| 505 |
0 |
0 |
|g 57
|t Glycans in biotechnology and the pharmaceutical industry
|
| 505 |
0 |
0 |
|g 58
|t Glycans in nanotechnology
|
| 505 |
0 |
0 |
|g 59
|t Glycans in bioenergy and materials science
|
| 505 |
0 |
0 |
|g 60
|t Future directions in glycosciences
|
| 653 |
1 |
0 |
|a GLICOBIOLOGIA
|
| 700 |
1 |
|
|a Varki, Ajit
|
| 700 |
1 |
|
|a Cummings, Richard D.
|
| 700 |
1 |
|
|a Esko, Jeffrey D.
|
| 700 |
1 |
|
|a Stanley, Pamela
|
| 700 |
1 |
|
|a Hart, Gerald W.
|
| 700 |
1 |
|
|a Aebi, Markus
|
| 700 |
1 |
|
|a Mohnen, Debra
|
| 700 |
1 |
|
|a Kinoshita, Taroh
|
| 700 |
1 |
|
|a Packer, Nicolle H.
|
| 700 |
1 |
|
|a Prestegard, James H.
|
| 700 |
1 |
|
|a Schnaar, Ronald L.
|
| 700 |
1 |
|
|a Seeberger, Peter H.
|
| 962 |
|
|
|a info:ar-repo/semantics/libro
|a info:eu-repo/semantics/book
|b info:eu-repo/semantics/publishedVersion
|
| 999 |
|
|
|c 99372
|